Basics |
Sana Biotechnology, Inc.
|
IPO Date: |
February 1, 2021 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$751.52M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.36 | 4.25%
|
Avg Daily Range (30 D): |
$0.14 | 3.79%
|
Avg Daily Range (90 D): |
$0.13 | 4.42%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.71M |
Avg Daily Volume (30 D): |
5.16M |
Avg Daily Volume (90 D): |
4.52M |
Trade Size |
Avg Trade Size (Sh.): |
136 |
Avg Trade Size (Sh.) (30 D): |
226 |
Avg Trade Size (Sh.) (90 D): |
232 |
Institutional Trades |
Total Inst.Trades: |
1,307 |
Avg Inst. Trade: |
$1.87M |
Avg Inst. Trade (30 D): |
$.97M |
Avg Inst. Trade (90 D): |
$1.2M |
Avg Inst. Trade Volume: |
.24M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2M |
Avg Closing Trade (30 D): |
$1.01M |
Avg Closing Trade (90 D): |
$1.23M |
Avg Closing Volume: |
257.64K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$-1.06
|
$-.39
|
$-.21
|
Diluted EPS
|
$-1.06
|
$-.39
|
$-.21
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -252.18M
|
$ -93.8M
|
$ -49.39M
|
Operating Income / Loss
|
$ -258.23M
|
$ -94.98M
|
$ -50.63M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -63.32M
|
$ -24.86M
|
$ -31.07M
|
PE Ratio
|
|
|
|
|
|
|